Patient Analytics: quick answer患者数据分析：快速回答
Patient analytics organizes and analyzes attributes and events at the patient level. Patient journey analytics instead models sequences and friction across touchpoints, handoffs, and episodes over time.
患者数据分析围绕明确人群或照护目标，在患者层面组织属性和事件。相关资料应保留来源、时间和待确认问题，诊断或治疗判断仍由医疗专业人员负责。
Where patient analytics fits患者数据分析的适用范围
Population-health analysts, care-management teams, clinical services, and patient-outcomes researchers use patient analytics to analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective. The working evidence includes patient demographics, conditions, encounters, medications, observations, outcomes, access, adherence, and social-context variables with governance. These boundaries determine what a useful output must contain and which conclusions require professional review.
患者数据分析由相应临床、数据、信息管理和治理人员共同参与。相关资料需组织成可追溯、可复核的结果，并明确数据边界、不确定性、待确认问题与最终责任人。
Population-health analysts, care-management teams, clinical services, and patient-outcomes researchers.
应由具有相应职责和专业范围的人员完成最终解释与确认。
Analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective.
输出应保留来源、时间、不确定性、待确认问题和处置责任。
Evidence model for patient analytics患者数据分析所需证据模型
Patient analytics organizes attributes and events at the patient level for a defined population or care objective. Evidence can include demographics, conditions, medications, laboratory results, encounters, utilization, social or access factors, patient-reported outcomes, care plans, and longitudinal outcomes. Every measure needs an as-of date and a clear distinction between current state, historical event, predicted risk, and inferred need. Identity, consent, provenance, and minimum-necessary access are central because information is linked across time for the same person.
患者数据分析围绕明确人群或照护目标，在患者层面组织属性和事件。证据可以包括人口学信息、疾病、用药、检验、就诊、服务利用、社会或可及性因素、患者报告结局、照护计划和纵向结局。每项指标都需要截至日期，并明确区分当前状态、历史事件、预测风险和推断需求。由于信息会跨时间关联到同一患者，身份、同意、来源和最小必要访问是核心要求。
Interpret patient analytics without losing context在不丢失背景的情况下解释患者数据分析
Keep descriptive patient profiles separate from predictions and judgments. A refill gap can suggest a supply interruption but does not prove nonadherence; frequent encounters can reflect high need, fragmented access, or planned treatment; missing social information is not evidence that no barrier exists. Present the source and date behind each indicator and give care teams a way to correct it. Use segments to organize work, not to reduce a person to a permanent label.
应把描述性患者画像与预测和判断分开。续配间隔可能提示供应中断，但不能证明不依从；频繁就诊可能来自高需求、可及性碎片化或计划治疗；社会信息缺失也不代表没有障碍。每个指标都应展示来源和日期，并允许照护团队纠正。分层用于组织工作，不能把患者简化成永久标签。
How to carry out patient analytics如何执行患者数据分析
- Step 1. Define the patient population, care objective, as-of date, and action that the analysis may support.
- Step 2. Link patient-level sources using governed identity rules and preserve provenance and event time.
- Step 3. Construct interpretable features for status, utilization, outcomes, barriers, and unmet needs.
- Step 4. Segment or compare patients only with clinically and operationally meaningful definitions.
- Step 5. Route findings to an accountable care process and record review, outreach, correction, and outcome.
- 第 1 步。定义患者人群、照护目标、截至日期和分析可能支持的行动。
- 第 2 步。使用受治理身份规则连接患者级来源，并保留来源和事件时间。
- 第 3 步。构建可解释的状态、利用、结局、障碍和未满足需求特征。
- 第 4 步。只采用具有临床和运营意义的定义对患者分层或比较。
- 第 5 步。把发现送入明确负责的照护流程，并记录复核、联系、纠错和结果。
Working note 1. Begin by making the first action operational: define the patient population, care objective, as-of date, and action that the analysis may support. Name the person who can confirm scope, the time cutoff, the source systems that count, and the conditions that place a record outside the patient-level population analysis review. For patient analytics, a clear entry rule prevents a convenient dataset from silently replacing the intended population or clinical question. Preserve rejected records with a reason code so responsible specialists can distinguish a deliberate exclusion from a missing or failed import.
Working note 2. The second action is evidence control: link patient-level sources using governed identity rules and preserve provenance and event time. Write down when each item happened, when it became available, who entered or supplied it, whether it is preliminary or final, and how corrections are represented. The relevant material may include patient demographics, conditions, encounters, medications, observations, outcomes, access, adherence, and social-context variables with governance. Do not collapse two values merely because their labels look alike. A reviewer has to be able to return from a normalized field to the original record and understand every transformation in between.
Working note 3. At the third action, construct interpretable features for status, utilization, outcomes, barriers, and unmet needs. Establish the expected intermediate artifact before processing starts: a compared list, time-aligned cohort, mapped event, scored observation, or another output appropriate to patient analytics. Retain conflicts and uncertainty visible. When a source is incomplete, the operating sequence has to say whether the item is excluded, retained with a flag, estimated under a declared rule, or sent for clarification; silent imputation can make a clean result clinically misleading.
Working note 4. The fourth action requires contextual interpretation: segment or compare patients only with clinically and operationally meaningful definitions. Separate what the records directly show from what the accountable service infers, and record plausible alternative explanations. The objective is to analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective, not to convert a pattern into an unsupported diagnosis, causal claim, or treatment instruction. Reviewers has to see the denominator, comparison point, timing assumptions, and exceptions that could change the meaning of the output before any operational or clinical response is considered.
Working note 5. Close the cycle through the fifth action: route findings to an accountable care process and record review, outreach, correction, and outcome. Assign every unresolved item to a named role, define the response time, and record the final disposition without deleting the earlier state. The handoff has to include the source cutoff, version, material exceptions, validation status, and next review date. This makes patient analytics reproducible when another qualified member of population-health analysts, care-management teams, clinical services, and patient-outcomes researchers needs to reconstruct why the output was accepted, challenged, corrected, or left unresolved.
执行说明 1。首先把第一项行动落实为可执行规则：定义患者人群、照护目标、截至日期和分析可能支持的行动。需要明确谁有权确认范围、资料截止时间、哪些来源有效，以及什么条件会让记录不进入复核。对于患者数据分析，清晰的入口规则可以防止方便取得的数据悄然替代真正的人群或临床问题。被排除的记录仍应保留原因代码，使复核者能够区分主动排除、资料缺失和导入失败。
执行说明 2。第二项行动关注证据控制：使用受治理身份规则连接患者级来源，并保留来源和事件时间。每项资料都要记录事件发生时间、可用时间、录入或提供者、初步或最终状态，以及修订如何表示。相关资料必须覆盖患者数据分析所需的来源、时间、状态、编码、单位和上下文。不能因为标签相似就合并两个数值；复核者应能从规范化字段回到原始记录，并理解中间每一步转换。
执行说明 3。第三项行动是构建可解释的状态、利用、结局、障碍和未满足需求特征。处理开始前，应先定义符合患者数据分析需要的中间成果，例如对照清单、时间对齐人群、映射事件或带来源的观察结果。冲突和不确定性必须可见。来源不完整时，流程应说明是排除、带标记保留、按已声明规则估计，还是转交确认；静默填补可能让整洁结果产生错误临床含义。
执行说明 4。第四项行动要求结合背景解释：只采用具有临床和运营意义的定义对患者分层或比较。应区分记录直接显示的事实和团队作出的推断，并保留其他合理解释。目标是支持患者数据分析所界定的资料整理、分析和复核任务，而不是把模式直接写成未经支持的诊断、因果结论或治疗指令。在采取运营或临床响应前，复核者需要看到分母、比较点、时间假设和可能改变结论的例外。
执行说明 5。第五项行动用于闭环：把发现送入明确负责的照护流程，并记录复核、联系、纠错和结果。每个未解决项目都要分配给明确角色，规定响应时间，并在不删除先前状态的情况下记录最终处置。交接材料应包含来源截止时间、版本、重要例外、验证状态和下次复核日期，使另一位合格人员能够重建为何结果被接受、质疑、纠正或继续保持未解决。
Review gates for patient analytics患者数据分析复核关口
| Review gate复核关口 | Topic-specific question本主题问题 | Expected evidence预期证据 |
|---|---|---|
| Identity and scope身份与范围 | Does the record match the intended people, setting, and time window for patient analytics?记录是否符合患者数据分析所需的人群、场景和时间范围？ | Source register and dated inclusion rules来源登记与带日期的纳入规则 |
| Meaning含义 | Can the team distinguish the evidence needed to analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective?团队能否区分完成本主题任务所需的不同证据？ | Field definitions, status, provenance, and sampled source records字段定义、状态、来源和抽样原始记录 |
| Professional review专业复核 | Are uncertainty, exceptions, and the accountable reviewer visible?不确定性、例外和责任复核者是否清晰？ | Review note, disposition, and unresolved-question list复核记录、处置意见和待确认问题清单 |
| Acceptance验收 | Do the topic-specific measures show that the workflow is usable and reproducible?本主题指标能否证明流程可用且可复现？ | Versioned result, validation sample, and correction log版本化结果、验证样本和纠错日志 |
A worked patient analytics scenario患者数据分析工作示例
A care-management team defines a cohort with repeated acute-care use, then reviews longitudinal conditions, access barriers, follow-up, and medication history. The analysis prioritizes professional review and outreach, not automated treatment decisions. This is a hypothetical workflow example, not an individual clinical recommendation or a product-performance claim.
假设示例：照护管理团队希望识别需要记录复核的人群。分析把当前问题、近期利用、待完成监测和患者报告障碍按截至日期组织，并标记来源缺失。团队没有把续配间隔直接写成不依从，而是把它作为需要确认的问题交给照护人员，并记录联系结果和数据纠正。该示例只说明工作流，不构成个体化临床建议或产品效果声明。
Validation and operating measures for patient analytics患者数据分析的验证与运行指标
Validate patient identity, population inclusion, as-of logic, source coverage, feature definitions, and whether indicators remain current at review time. Measure unassigned or duplicate patients, missingness, correction rate, subgroup distribution, outreach completion, and the proportion of findings that professionals consider relevant. If risk or prioritization is used, assess calibration and workload as well as discrimination. Monitor whether the process improves the intended service without widening access or outcome gaps.
应验证患者身份、人群纳入、截至日期逻辑、来源覆盖、特征定义，以及复核时指标是否仍然有效。监测未归属或重复患者、缺失、纠错率、亚组分布、联系完成情况和专业人员认为相关的发现比例。若使用风险或优先排序，应同时评估校准、工作量和区分度，并监测流程是否改善目标服务而没有扩大可及性或结局差距。
Failure modes and limits of patient analytics患者数据分析的失败模式与限制
Patient-level data are often incomplete across organizations and can reflect unequal access to testing or care. Proxies for need, adherence, or social conditions can embed bias and may be wrong for an individual. Segmentation can stigmatize or exclude people when labels are reused beyond their intended purpose. Use the smallest necessary data, allow correction, review subgroup effects, and require professional assessment before patient analytics changes care, prioritization, or communication.
患者级数据在不同机构之间经常不完整，也可能反映检查或照护可及性不平等。对需求、依从性或社会状况的代理变量可能包含偏倚，并且对个体并不准确；分层标签若超出原用途复用，还可能污名化或排除患者。应使用最小必要数据、允许纠正、复核亚组影响，并在患者分析改变照护、优先级或沟通前完成专业评估。
Organized records and tool output support trend recognition and professional decisions. Drug interactions, risk predictions, diagnoses, and treatment conclusions require qualified medical review.
整理后的资料和工具输出仅用于趋势识别和专业决策辅助。药物相互作用、风险预测、诊断与治疗结论必须由合格医疗专业人员审核。
Operate patient analytics as a controlled workflow把患者数据分析作为受控工作流运行
Turn patient analytics into a written operating brief before configuring a dashboard, rule, model, or review queue. Name the intended users—population-health analysts, care-management teams, clinical services, and patient-outcomes researchers—and state the decision, time available, acceptable uncertainty, and consequence of a delayed or incorrect result. The brief has to use the bounded objective to analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective. Requests such as “show insights” or “find risk” are not testable until the population, event, time window, owner, and permitted action are explicit.
Create a source register for patient demographics, conditions, encounters, medications, observations, outcomes, access, adherence, and social-context variables with governance. For every source, document its steward, collection process, event time, availability time, status model, code or unit system, revision behavior, coverage, and known gaps. Then connect the first two workflow actions—define the patient population, care objective, as-of date, and action that the analysis may support and link patient-level sources using governed identity rules and preserve provenance and event time—to named fields and documents. This prevents a familiar label from being treated as equivalent across systems when the underlying event or meaning is different.
Build test records before full use of patient analytics. Include ordinary cases, missing fields, duplicate identities, conflicting sources, late events, corrected values, unusual but valid states, and records that has to not enter the operating sequence. Use the middle action, construct interpretable features for status, utilization, outcomes, barriers, and unmet needs, to define expected results for each case. Retain the expected professional explanation beside the technical expectation so a passing transformation does not conceal an interpretation error.
Separate technical acceptance from domain acceptance. Technical review shows that inputs arrive, mappings run, calculations reproduce, permissions work, and failures are visible. Domain review asks whether the information has the correct meaning for patient analytics, reaches the intended professional at the right moment, and supports a safe response. The later workflow actions—segment or compare patients only with clinically and operationally meaningful definitions and route findings to an accountable care process and record review, outreach, correction, and outcome—has to be demonstrated in the real interface rather than inferred from a data extract.
Establish correction, escalation, and change control before launch. Users need a route to challenge a result, repair a source or mapping, annotate an exception, and determine which prior outputs are affected. Version the source contract, terminology, logic, thresholds, display, and review policy. When any material element changes, compare new and previous results on representative records, decide whether earlier patient analytics outputs remain valid, and document who approved the release and who can roll it back.
The final patient analytics handoff has to let another qualified reviewer understand and reproduce the output without relying on undocumented team knowledge. Include the purpose, inclusion rules, source inventory, data cutoff, original evidence links, transformations, workflow state, exceptions, validation results, reviewer disposition, and unresolved questions. Add the specific evidence used to analyze patient-level status, needs, risk, utilization, and outcomes for a defined population or care objective, identify which statements are observed versus inferred, and state the next review date. Sensitive details has to remain only in approved systems with role-appropriate access and retention.
在配置仪表板、规则、模型或复核队列前，应先把患者数据分析写成运行说明。明确目标用户、支持的决策、可用时间、可接受不确定性，以及延迟或错误结果的后果。说明中必须写清人群、事件、时间窗口、责任人和允许采取的行动；“寻找洞察”或“发现风险”等宽泛要求无法直接测试和验收。
针对患者数据分析所需资料建立来源登记表。每个来源都应记录数据责任人、采集过程、事件时间、可用时间、状态模型、编码或单位体系、修订方式、覆盖范围和已知缺口。随后把前两个工作步骤——定义患者人群、照护目标、截至日期和分析可能支持的行动和使用受治理身份规则连接患者级来源，并保留来源和事件时间——落实到具体字段和文档，防止把名称相似但事件含义不同的数据直接视为等价。
全面使用患者数据分析前应建立测试记录，覆盖普通情况、字段缺失、身份重复、来源冲突、事件延迟、数值修订、少见但有效的状态，以及本来不应进入流程的记录。围绕“构建可解释的状态、利用、结局、障碍和未满足需求特征”为每个测试病例写出预期结果，并把专业解释与技术预期放在一起，避免技术转换通过却隐藏解释错误。
技术验收和领域验收必须分开。技术复核证明输入到达、映射运行、计算可复现、权限有效且失败可见；领域复核则确认信息对患者数据分析含义正确、在合适时间到达目标专业人员并支持安全响应。后两个步骤——只采用具有临床和运营意义的定义对患者分层或比较和把发现送入明确负责的照护流程，并记录复核、联系、纠错和结果——应在真实界面和工作流中演示，不能只从数据抽取结果推断。
上线前定义纠错、升级和变更控制。使用者需要能够质疑结果、修复来源或映射、标注例外，并判断哪些既往输出受到影响。来源合同、术语、逻辑、阈值、显示和复核制度都应进行版本管理；任何重大变化后，都要在代表性记录上比较新旧结果，判断既往患者数据分析输出是否仍有效，并记录批准者和回滚责任人。
最终患者数据分析交接包应让另一位合格复核者无需依赖团队未记录的知识，就能理解并复现结果。材料应包含目的、纳入规则、来源清单、数据截止时间、原始证据链接、转换过程、工作流状态、例外、验证结果、复核处置和待确认问题；还要区分观察与推断、说明下次复核日期，并把敏感详情限制在具有适当访问和保留控制的获批系统中。
Prepare patient analytics evidence with 医数智析用医数智析准备患者数据分析资料
Before opening the workspace, prepare patient demographics, conditions, encounters, medications, observations, outcomes, access, adherence, and social-context variables with governance. 医数智析 can help organize those materials into a longitudinal record, expose missing or conflicting entries, and make cross-time patterns available for professional review. Final clinical interpretation remains with qualified professionals.
打开工作区前，请准备与患者数据分析直接相关的原始资料、日期和来源。医数智析可帮助整理纵向记录、暴露缺失或冲突，并把跨时间变化呈现给专业人员复核；最终临床解释仍由合格专业人员负责。
View the 医数智析 tool page查看医数智析工具页 Open the live experience打开实际体验页Patient Analytics questions患者数据分析常见问题
No. Segments summarize selected attributes for a defined operational or analytical purpose. They may hide within-group variation and must not be treated as diagnoses or treatment rules.
患者数据分析研究患者级状态、需求、风险、利用和结局；患者旅程分析重点重建跨接触点和照护阶段的顺序与摩擦。
It states the point in time at which the profile or measure is intended to be current and prevents later events from being treated as already known.
它说明画像或指标在哪个时间点被视为当前状态，并防止把之后发生的事件当作当时已经知道。
No. Segments are purpose- and time-specific analytical groupings. They should be refreshed, reviewable, and not reused for unrelated decisions.
不能。分层是特定目的和时间下的分析分组，应可更新、可复核，也不能用于无关决策。
Primary source for patient analytics患者数据分析的主要参考来源
Use the cited primary or official source together with current organizational policy and the professional standards that apply in the intended setting.
实施时应把下列第一方或权威来源与当前机构制度及适用专业标准结合使用。